Terms: = Kidney tumors AND MALAT1, PRO1073, 378938, Q9UHZ2
40 results:
1. Beyond the genome: malat1's role in advancing urologic cancer care.
Imran M; Abida ; Eltaib L; Siddique MI; Kamal M; Asdaq SMB; Singla N; Al-Hajeili M; Alhakami FA; AlQarni AF; Abdulkhaliq AA; Rabaan AA
Pathol Res Pract; 2024 Apr; 256():155226. PubMed ID: 38452585
[TBL] [Abstract] [Full Text] [Related]
2. Comparative genomics incorporating translocation renal cell carcinoma mouse model reveals molecular mechanisms of tumorigenesis.
Prakasam G; Mishra A; Christie A; Miyata J; Carrillo D; Tcheuyap VT; Ye H; Do QN; Wang Y; Reig Torras O; Butti R; Zhong H; Gagan J; Jones KB; Carroll TJ; Modrusan Z; Durinck S; Requena-Komuro MC; Williams NS; Pedrosa I; Wang T; Rakheja D; Kapur P; Brugarolas J
J Clin Invest; 2024 Feb; 134(7):. PubMed ID: 38386415
[TBL] [Abstract] [Full Text] [Related]
3. Exosomal long non-coding RNA malat1: a candidate of liquid biopsy in monitoring of Wilms' tumor.
Sharma D; Singh A; Wilson C; Swaroop P; Kumar S; Yadav DK; Jain V; Agarwala S; Husain M; Sharawat SK
Pediatr Surg Int; 2024 Feb; 40(1):57. PubMed ID: 38353772
[TBL] [Abstract] [Full Text] [Related]
4. The functions of long non-coding RNA (lncRNA)-MALAT-1 in the pathogenesis of renal cell carcinoma.
Anbiyaee O; Moalemnia A; Ghaedrahmati F; Shooshtari MK; Khoshnam SE; Kempisty B; Halili SA; Farzaneh M; Morenikeji OB
BMC Nephrol; 2023 Dec; 24(1):380. PubMed ID: 38124072
[TBL] [Abstract] [Full Text] [Related]
5. Anoikis-related genes signature development for clear cell renal cell carcinoma prognosis and tumor microenvironment.
Jiang Y; Wang Y; Wang Z; Zhang Y; Hou Y; Wang X
Sci Rep; 2023 Nov; 13(1):18909. PubMed ID: 37919386
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic significance of malat1 in clear cell renal cell carcinoma based on TCGA and GEO.
Liu K; Gao Y; Zhang Q
Medicine (Baltimore); 2023 Sep; 102(37):e35249. PubMed ID: 37713833
[TBL] [Abstract] [Full Text] [Related]
7. The Role of HIF1-related Genes and Non-coding RNAs Expression in Clear Cell Renal Cell Carcinoma.
Grammatikaki S; Katifelis H; Stravodimos K; Bakolas E; Kavantzas N; Grigoriadou D; Gazouli M
In Vivo; 2023; 37(3):1103-1110. PubMed ID: 37103094
[TBL] [Abstract] [Full Text] [Related]
8. The Role of Long Noncoding RNA (lncRNAs) Biomarkers in Renal Cell Carcinoma.
Rysz J; Konecki T; Franczyk B; Ławiński J; Gluba-Brzózka A
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614082
[TBL] [Abstract] [Full Text] [Related]
9. Identification of Novel Prognostic Signatures for Clear Cell Renal Cell Carcinoma Based on ceRNA Network Construction and Immune Infiltration Analysis.
Zhou L; Ye J; Wen F; Yu H
Dis Markers; 2022; 2022():4033583. PubMed ID: 35320950
[TBL] [Abstract] [Full Text] [Related]
10. A review of neoplasms with MITF/MiT family translocations.
Wei S; Testa JR; Argani P
Histol Histopathol; 2022 Apr; 37(4):311-321. PubMed ID: 35107169
[TBL] [Abstract] [Full Text] [Related]
11. Translocation carcinomas of the kidney.
Argani P
Genes Chromosomes Cancer; 2022 May; 61(5):219-227. PubMed ID: 34704642
[TBL] [Abstract] [Full Text] [Related]
12. LncRNAs in the Regulation of Genes and Signaling Pathways through miRNA-Mediated and Other Mechanisms in Clear Cell Renal Cell Carcinoma.
Braga EA; Fridman MV; Filippova EA; Loginov VI; Pronina IV; Burdennyy AM; Karpukhin AV; Dmitriev AA; Morozov SG
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681854
[TBL] [Abstract] [Full Text] [Related]
13. MiT family translocation renal cell carcinoma in an elderly male.
Prachi ; Aiyer HM
Indian J Pathol Microbiol; 2021; 64(3):553-555. PubMed ID: 34341271
[TBL] [Abstract] [Full Text] [Related]
14. Mechanism of tumor‑derived extracellular vesicles in regulating renal cell carcinoma progression by the delivery of malat1.
Jin C; Shi L; Li K; Liu W; Qiu Y; Zhao Y; Zhao B; Li Z; Li Y; Zhu Q
Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34278501
[TBL] [Abstract] [Full Text] [Related]
15. TFEB rearranged renal cell carcinoma. A clinicopathologic and molecular study of 13 cases. tumors harboring malat1-TFEB, ACTB-TFEB, and the novel NEAT1-TFEB translocations constantly express PDL1.
Caliò A; Harada S; Brunelli M; Pedron S; Segala D; Portillo SC; Magi-Galluzzi C; Netto GJ; Mackinnon AC; Martignoni G
Mod Pathol; 2021 Apr; 34(4):842-850. PubMed ID: 33208882
[TBL] [Abstract] [Full Text] [Related]
16. A Tale of 2 Morphologies: Diagnostic Pitfalls in
Sharma AE; Parilla M; Wanjari P; Segal JP; Antic T
Int J Surg Pathol; 2021 Feb; 29(1):21-29. PubMed ID: 32886007
[TBL] [Abstract] [Full Text] [Related]
17. Depletion of lncRNA malat1 inhibited sunitinib resistance through regulating miR-362-3p-mediated G3BP1 in renal cell carcinoma.
Wang Z; Chang X; Zhu G; Gao X; Chang L
Cell Cycle; 2020 Aug; 19(16):2054-2062. PubMed ID: 32663095
[TBL] [Abstract] [Full Text] [Related]
18. Noncoding RNAs orchestrate cell growth, death and drug resistance in renal cell carcinoma.
Fawzy MS; Toraih EA; Ageeli EA; Al-Qahtanie SA; Hussein MH; Kandil E
Epigenomics; 2020 Feb; 12(3):199-219. PubMed ID: 32011160
[No Abstract] [Full Text] [Related]
19. Clinicopathologic and Molecular Analysis of the TFEB Fusion Variant Reveals New Members of TFEB Translocation Renal Cell Carcinomas (RCCs): Expanding the Genomic Spectrum.
Xia QY; Wang XT; Fang R; Wang Z; Zhao M; Chen H; Chen N; Teng XD; Wang X; Wei X; Ye SB; Li R; Ma HH; Lu ZF; Zhou XJ; Rao Q
Am J Surg Pathol; 2020 Apr; 44(4):477-489. PubMed ID: 31764220
[TBL] [Abstract] [Full Text] [Related]
20. Long non-coding RNAs and nuclear factor-κB crosstalk in cancer and other human diseases.
Gupta SC; Awasthee N; Rai V; Chava S; Gunda V; Challagundla KB
Biochim Biophys Acta Rev Cancer; 2020 Jan; 1873(1):188316. PubMed ID: 31639408
[TBL] [Abstract] [Full Text] [Related]
[Next]
